Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04627675
Recruitment Status : Active, not recruiting
First Posted : November 13, 2020
Last Update Posted : June 3, 2021
OncoSec Medical Incorporated
Information provided by (Responsible Party):
Providence Health & Services

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : May 2022